Publications by authors named "Mark Sanz"

Claim this Profile
A
A method to estimate the mean lifetime survival increase of statin therapy.
Shu-Ching Chang, Mansen Wang, James G Beckerman, Mark Sanz, Tyler J Gluckman

Future Cardiol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Hemal Gada, Ajay J Kirtane, William Newman, Mark Sanz, James B Hermiller

JACC Cardiovasc Interv· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee.
Mary Norine Walsh, Alfred A Bove, Russell R Cross, Keith C Ferdinand, Daniel E Forman, Mark L Sanz

J Am Coll Cardiol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
James B Hermiller, Eugenia Nikolsky, Alexandra J Lansky, Robert J Applegate, Mark Sanz

EuroIntervention· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
Alexandra J Lansky, Manejeh Yaqub, James B Hermiller, Robert S Smith, Naim Farhat, Mark Sanz

EuroIntervention· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Robert J Applegate, James J Hermiller, Mark Sanz, Julie Doostzadeh, Wesley Pierson

EuroIntervention· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Alexandra J Lansky, Vivian G Ng, Halil Mutlu, Ecaterina Cristea, Julian Benetato Guiran, Mark Sanz

Catheter Cardiovasc Interv· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Gregg W Stone, Mark Midei, William Newman, Mark Sanz, James B Hermiller

Circulation· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
Gregg W Stone, Mark Midei, William Newman, Mark Sanz, James B Hermiller

JAMA· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of systems of care for ST-elevation myocardial infarction patients: the physician perspective.
Mark Sanz, Richard W Smalling, David L Brewer, William J French, Lynn A Smaha

Circulation· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An experimental method for the percutaneous induction of a posterolateral infarct and functional ischemic mitral regurgitation.
Thomas M Joudinaud, Corrine L Kegel, Alan A Gabster, Mark L Sanz, Alistair MacDonald

J Heart Valve Dis· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis